Tearsheet

Cantor Equity Partners I (CEPO)

Market Price (10/31/2025): $10.51 | Market Cap: $268.0 Mil
Sector: Financials | Industry: Multi-Sector Holdings

Cantor Equity Partners I (CEPO)

Market Price (10/31/2025): $10.51
Market Cap: $268.0 Mil
Sector: Financials
Industry: Multi-Sector Holdings

Investment Highlights Why It Matters Which of these 2 stories sounds closer for this stock?

1. Generates cash flow

The stock generated 4% or more of the share price (called cash flow yield), and shows moderate 10-15% or more growth.

2. Riding a trend

Think Tesla during the pandemic of 2020 when EVs were riding a cultural high, or Nvidia in the current AI boom, or even Figma. These companies don’t have enough yield, or, enough growth, or both - however - they are riding a trend. They have momentum. These can be more volatile - they don’t have the floor of strong cash flow

0			Very low revenue Rev LTMTotal Revenue or Sales, Last Twelve Months is 0
1			Not profitable at operating income level Op Inc LTMOperating Income, Last Twelve Months is -0.4 Mil
2			Expensive valuation multiples P/EPrice/Earnings or Price/(Net Income) is 92x
3			Stock price has recently run up significantly 12M Rtn12 month market price return is 656150%
4			Yield minus risk free rate is negative ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -3.4%
5			High stock price volatility Vol 12M is 628025%

0	Very low revenue Rev LTMTotal Revenue or Sales, Last Twelve Months is 0
1	Not profitable at operating income level Op Inc LTMOperating Income, Last Twelve Months is -0.4 Mil
2	Expensive valuation multiples P/EPrice/Earnings or Price/(Net Income) is 92x
3	Stock price has recently run up significantly 12M Rtn12 month market price return is 656150%
4	Yield minus risk free rate is negative ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -3.4%
5	High stock price volatility Vol 12M is 628025%

Market Valuation & Key Metrics

Valuation
Key Metrics

	10/31/25	2024	2023	2022
Share Price CYE	$10.51	$0.00	$0.00	$0.00
Market Cap CYE ($ Mil)	268.0	0.0	0.0	0.0
Total Debt ($ Mil)	0.2	0.1	0.0	0.0
Total Cash ($ Mil)	0.0	0.0	0.0	0.0
Enterprise Value ($ Mil)	268.2	0.1	0.0	0.0
Valuation Ratios
P/S TTM	0.0	0.0	0.0	0.0
P/EBIT TTM	-656.8	-0.5	-11.8	-6.5
P/E TTM	92.2	-0.5	-11.8	-6.5
Sector Ratios
P/S TTM (Sector)	3.0	3.0	2.8	2.7
P/EBIT TTM (Sector)	6.8	6.8	7.0	6.2
P/E TTM (Sector)	11.8	11.5	10.1	9.3

	10/31/25	2024	2023
Share Price CYE	$10.51	$0.00	$0.00
Market Cap CYE ($ Mil)	268.0	0.0	0.0
Total Debt ($ Mil)	0.2	0.1	0.0
Total Cash ($ Mil)	0.0	0.0	0.0
Enterprise Value ($ Mil)	268.2	0.1	0.0
Valuation Ratios
P/S TTM	0.0	0.0	0.0
P/EBIT TTM	-656.8	-0.5	-11.8
P/E TTM	92.2	-0.5	-11.8
Sector Ratios
P/S TTM (Sector)	3.0	3.0	2.8
P/EBIT TTM (Sector)	6.8	6.8	7.0
P/E TTM (Sector)	11.8	11.5	10.1

	CEPO	S&P 500
REVENUE GROWTH	FAIR
Rev LTM ($ Bil)	0.0
Rev Chg Q	�	6.4%
Rev Chg LTM	�	5.4%
VALUATION	VERY HIGH
P/CFO	-3,281.9	15.5
P/FCF	-3,281.9	20.6
P/E	92.2	23.6

CEPO Stock

Return (1M):

Factor Drivers of Stock Movement

The -4.1% change in CEPO stock from 7/31/2025 to 10/30/2025 was primarily driven by a -60.6% change in the company's P/E Multiple.

	7312025	10302025	Change
Stock Price ($)	10.95	10.50	-4.11%
Change Contribution By	LTM	LTM
Total Revenues ($ Mil)	0.00	0.00	�
Net Income Margin (%)	∞%	∞%	�
P/E Multiple	233.76	92.09	-60.61%
Shares Outstanding (Mil)	19.41	25.50	-31.41%
Cumulative Contribution			�

LTM = Last Twelve Months as of date shown

The -12.0% change in CEPO stock from 5/1/2025 to 10/30/2025 was primarily driven by a 0.0% change in the company's Shares Outstanding (Mil).

	5012025	10302025	Change
Stock Price ($)	11.93	10.50	-11.99%
Change Contribution By	LTM	LTM
Total Revenues ($ Mil)	0.00	0.00	�
P/S Multiple	∞	∞	�
Shares Outstanding (Mil)	25.50	25.50	0.00%
Cumulative Contribution			�

LTM = Last Twelve Months as of date shown

The 656150.0% change in CEPO stock from 10/30/2024 to 10/30/2025 was primarily driven by a 0.0% change in the company's P/E Multiple.

	10302024	10302025	Change
Stock Price ($)	0.00	10.50	656150.00%
Change Contribution By	LTM	LTM
Total Revenues ($ Mil)	�	0.00	�
Net Income Margin (%)	�	∞%	�
P/E Multiple	�	92.09	�
Shares Outstanding (Mil)	25.50	25.50	0.00%
Cumulative Contribution			�

LTM = Last Twelve Months as of date shown

null

null

Return vs. Risk

Price Returns Compared

	2020	2021	2022	2023	2024	2025	Total [1]
Returns
CEPO Return	0%	0%	0%	0%	0%	656150%	655525%
Peers Return							0%
S&P 500 Return	16%	27%	-19%	24%	23%	16%	110%
Monthly Win Rates [3]
CEPO Win Rate	0%	0%	0%	0%	0%	56%
Peers Win Rate						62%
S&P 500 Win Rate	58%	75%	42%	67%	75%	67%
Max Drawdowns [4]
CEPO Max Drawdown	0%	0%	0%	0%	0%	0%
Peers Max Drawdown
S&P 500 Max Drawdown	-31%	-1%	-25%	-1%	-2%	-15%

[1] Cumulative total returns since the beginning of 2020
[2] Peers: BCAR, AEXA, BACC, BRR, CCCX.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2025 data is for the year up to 10/30/2025 (YTD)

How Low Can It Go

Unique Key	Event	CEPO	S&P 500
2008 Global Financial Crisis	2008 Global Financial Crisis
2008 Global Financial Crisis% Loss	% Loss	-99.7%	-56.8%
2008 Global Financial Crisis% Gain to Breakeven	% Gain to Breakeven	34100.0%	131.3%
2008 Global Financial CrisisTime to Breakeven	Time to Breakeven	5858 days	1480 days

Compare to BCAR, AEXA, BACC, BRR, CCCX

In The Past

Cantor Equity Partners I's stock fell -99.7% during the 2008 Global Financial Crisis from a high on 2/22/2007. A -99.7% loss requires a 34100.0% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth over time.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About Cantor Equity Partners I (CEPO)

Business Description

We are a blank check company incorporated on November 11, 2020 as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination. We have not selected any specific business combination target and we have not, nor has anyone on our behalf, initiated any discussions, directly or indirectly, with any business combination target regarding an initial business combination with our company. Our efforts to identify a prospective target business will not be limited to a particular industry or geographic region, although we expect to focus on a target in an industry where we believe our management team’s and our affiliates’ expertise will provide us with a competitive advantage, including the financial services, healthcare, real estate services, technology and software industries. Further, our efforts to identify a prospective target business will not be limited to any characteristics, although we expect to favor potential target companies with certain characteristics which include, but are not limited to, positive long term growth prospects, competitive advantages, consolidation opportunities, recurring revenue or the potential for recurring revenue, opportunities for operational improvement and attractive margins or the potential for attractive margins. --- We, our sponsor, and CF&Co. are all affiliates of Cantor. Cantor is a diversified company primarily specializing in financial and real estate services for customers operating in the global financial and commercial real estate markets. Cantor’s businesses include CF&Co., a leading independent middle market investment bank and primary dealer; a controlling interest in BGC Group, Inc., or BGC, whose Class A common stock trades on the Nasdaq Global Select Market under the ticker symbol “BGC”, a leading global brokerage and technology company primarily servicing the global financial markets; and a controlling interest in Newmark Group, Inc., or Newmark, whose Class A common stock trades on the Nasdaq Global Select Market under the ticker symbol “NMRK”, a leading full-service commercial real estate services business. We believe that the combination of our management team’s and our affiliates’ financial services, financial and real estate technology, and real estate industry expertise and proven ability to grow businesses through acquisitions make us uniquely qualified to pursue acquisitions. Our executive offices are located at 110 East 59th Street, New York, New York.

Better Bets than Cantor Equity Partners I (CEPO)

	CEPO	Better Performance than CEPO
Metric	Value	Industry (Multi-Sector Holdings)
Total Yield	1.1%	JEF (6.4%), VOYA (10.0%), ALDF (1.3%), ANSC (1.2%), EQV (2.8%)

	CEPO	Better Performance than CEPO
Metric	Value	Sector (Financials)
Total Yield	1.1%	JPM (6.6%), V (3.7%), MA (2.6%), BAC (6.8%), WFC (9.3%)

	CEPO	Better Performance than CEPO
Metric	Value	All Other Sectors
Total Yield	1.1%	NVDA (1.8%), AAPL (2.8%), MSFT (3.3%), GOOGL (3.9%), AMZN (3.0%)

		Best Bets In Financials Sector
	CEPO	DBRG	OTF	MTG	NMIH	CACC	ENVA	FNF	ACGL	APAM	FI
What You Pay
P/E	92.1	39.7	13.2	8.4	7.5	12.3	10.2	13.9	8.6	10.5	10.6
P/EBIT	-656.2	64.7	9.0	6.4	5.5	9.9	7.8	8.9	7.6	6.1	5.8
What You Get
Rev Chg Q	�	-102.4%	1,228.5%	-0.7%	7.2%	8.3%	16.3%	16.8%	22.4%	4.4%	8.0%
Rev Chg LTM	�	-84.8%	89.0%	2.2%	10.0%	12.5%	21.1%	7.4%	23.5%	10.0%	6.7%
Rev Chg 3Y Avg	�	125.8%	221.9%	1.2%	10.1%	6.9%	23.5%	-0.7%	29.8%	0.2%	7.5%
FCF/Rev 3Y Avg	�	101.2%	76.2%	62.2%	58.8%	57.1%	54.7%	50.8%	38.4%	29.0%	20.7%

[1] Choosing top 10 best bets from each sector quarterly is an alpha producing strategy vs sector benchmark
[2] Historical annualized return of 21%, alpha of 9.1%, and sharpe of 0.94

Latest Trefis Analyses

	Title	Topic
0	DASHBOARDS
1	How Low Can Cantor Equity Partners I Stock Really Go?	Return

	Title
0	ARTICLES
1	How Low Can Cantor Equity Partners I Stock Really Go?

Trade Ideas

Select past ideas related to CEPO. For more, see Trefis Trade Ideas.

Unique Key	Date	Ticker	Company	Category	Trade Strategy	6M Fwd Rtn	12M Fwd Rtn	12M Max DD
HLNE_9302025_Dip_Buyer_FCFYield	09302025	HLNE	Hamilton Lane	Dip Buy	DB \| FCFY OPMDip Buy with High FCF Yield and High Margin Buying dips for companies with high FCF yield and meaningfully high operating margin	-14.4%	-14.4%	-14.4%
CNS_9302025_Dip_Buyer_ValueBuy	09302025	CNS	Cohen & Steers	Dip Buy	DB \| P/E OPMDip Buy with Low PE and High Margin Buying dips for companies with tame PE and meaningfully high operating margin	5.9%	5.9%	-1.6%
JKHY_9262025_Monopoly_xInd_xCD_Getting_Cheaper	09262025	JKHY	Jack Henry & Associates	Monopoly	MY \| Getting CheaperMonopoly-Like with P/S Decline Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple	0.3%	0.3%	-2.1%
FDS_9192025_Monopoly_xInd_xCD_Getting_Cheaper	09192025	FDS	FactSet Research Systems	Monopoly	MY \| Getting CheaperMonopoly-Like with P/S Decline Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple	-7.7%	-7.7%	-7.7%
IBKR_9052025_Quality_Momentum_RoomToRun_10%	09052025	IBKR	Interactive Brokers	Quality	Q \| Momentum \| UpsideQuality Stocks with Momentum and Upside Buying quality stocks with strong momentum but still having room to run	15.0%	15.0%	0.0%

Unique Key	Date	Ticker	Company	Category	Trade Strategy	6M Fwd Rtn	12M Fwd Rtn	12M Max DD
HLNE_9302025_Dip_Buyer_FCFYield	09302025	HLNE	Hamilton Lane	Dip Buy	DB \| FCFY OPMDip Buy with High FCF Yield and High Margin Buying dips for companies with high FCF yield and meaningfully high operating margin	-14.4%	-14.4%	-14.4%
CNS_9302025_Dip_Buyer_ValueBuy	09302025	CNS	Cohen & Steers	Dip Buy	DB \| P/E OPMDip Buy with Low PE and High Margin Buying dips for companies with tame PE and meaningfully high operating margin	5.9%	5.9%	-1.6%
JKHY_9262025_Monopoly_xInd_xCD_Getting_Cheaper	09262025	JKHY	Jack Henry & Associates	Monopoly	MY \| Getting CheaperMonopoly-Like with P/S Decline Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple	0.3%	0.3%	-2.1%
FDS_9192025_Monopoly_xInd_xCD_Getting_Cheaper	09192025	FDS	FactSet Research Systems	Monopoly	MY \| Getting CheaperMonopoly-Like with P/S Decline Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple	-7.7%	-7.7%	-7.7%
IBKR_9052025_Quality_Momentum_RoomToRun_10%	09052025	IBKR	Interactive Brokers	Quality	Q \| Momentum \| UpsideQuality Stocks with Momentum and Upside Buying quality stocks with strong momentum but still having room to run	15.0%	15.0%	0.0%

Recent Active Movers

1 Day Top Gainers

#	Ticker	Company	1D Rtn	YTD Rtn
1	GH	Guardant Health	27.9%	202.5%
2	GCI	Gannett	27.7%	3.8%
3	FORM	FormFactor	24.2%	34.7%
4	VIAV	Viavi Solutions	22.3%	69.3%
5	GSAT	Globalstar	22.2%	63.5%
6	MTSR	Metsera	22.1%	63729900.0%
7	PRM	Perimeter Solutions	21.1%	102.3%
8	CHRW	C.H. Robinson Worldwide	19.7%	52.6%
9	INSM	Insmed	16.3%	181.3%
10	CAH	Cardinal Health	15.4%	62.8%

1 Day Top Losers

#	Ticker	Company	1D Rtn	YTD Rtn
1	FMC	FMC	-46.5%	-66.6%
2	APLS	Apellis Pharmaceuticals	-31.0%	-35.0%
3	THRY	Thryv	-30.2%	-44.8%
4	SFM	Sprouts Farmers Market	-26.1%	-39.2%
5	IART	Integra Lifesciences	-23.5%	-47.9%
6	ITRI	Itron	-21.1%	0.4%
7	WOLF	Wolfspeed	-18.2%
8	CMG	Chipotle Mexican Grill	-18.2%	-46.1%
9	CI	Cigna	-17.4%	-9.2%
10	EME	EMCOR	-16.6%	43.0%

1 Week Top Gainers

#	Ticker	Company	1W Rtn	YTD Rtn
1	INBX	Inhibrx Biosciences	176.8%	409.8%
2	PUMP	ProPetro	71.2%	16.2%
3	RNA	Avidity Biosciences	43.5%	139.6%
4	DYN	Dyne Therapeutics	42.8%	-0.0%
5	GCI	Gannett	39.3%	3.8%
6	FORM	FormFactor	38.3%	34.7%
7	MBX	MBX Biosciences	35.1%	18.2%
8	BBNX	Beta Bionics	33.8%
9	GH	Guardant Health	33.3%	202.5%
10	LUMN	Lumen Technologies	32.7%	94.7%

1 Week Top Losers

#	Ticker	Company	1W Rtn	YTD Rtn
1	PMI	Picard Medical	-75.2%	5106.3%
2	LRN	Stride	-56.1%	-35.8%
3	NTLA	Intellia Therapeutics	-52.6%	5.2%
4	FMC	FMC	-48.7%	-66.6%
5	FI	Fiserv	-47.4%	-68.3%
6	VRNS	Varonis Systems	-43.8%	-21.2%
7	THRY	Thryv	-33.4%	-44.8%
8	NFE	New Fortress Energy	-30.5%	-91.9%
9	AKBA	Akebia Therapeutics	-29.5%	10.5%
10	UAMY	United States Antimony	-28.9%	371.2%

1 Month Top Gainers

#	Ticker	Company	1M Rtn	YTD Rtn
1	PRAX	Praxis Precision Medicines	279.1%	161.2%
2	INBX	Inhibrx Biosciences	131.0%	409.8%
3	PUMP	ProPetro	99.6%	16.2%
4	DYN	Dyne Therapeutics	88.4%	-0.0%
5	VICR	Vicor	85.4%	89.2%
6	CELC	Celcuity	74.6%	503.2%
7	GLUE	Monte Rosa Therapeutics	73.5%	87.5%
8	NVTS	Navitas Semiconductor	72.1%	251.8%
9	LUMN	Lumen Technologies	70.3%	94.7%
10	BALY	Ballys	63.4%	4.1%

1 Month Top Losers

#	Ticker	Company	1M Rtn	YTD Rtn
1	PMI	Picard Medical	-62.9%	5106.3%
2	LRN	Stride	-53.8%	-35.8%
3	FMC	FMC	-51.0%	-66.6%
4	FI	Fiserv	-48.3%	-68.3%
5	NFE	New Fortress Energy	-43.6%	-91.9%
6	VG	Venture Global	-41.7%
7	OGN	Organon	-40.2%	-55.0%
8	VRNS	Varonis Systems	-39.5%	-21.2%
9	ITGR	Integer	-38.5%	-52.2%
10	LENZ	LENZ Therapeutics	-37.9%	5.5%

Recent Active Movers

1 Day Top Gainers

#	Ticker	Company	1D Rtn	YTD Rtn
1	GH	Guardant Health	27.9%	202.5%
2	GCI	Gannett	27.7%	3.8%
3	FORM	FormFactor	24.2%	34.7%
4	VIAV	Viavi Solutions	22.3%	69.3%
5	GSAT	Globalstar	22.2%	63.5%
6	MTSR	Metsera	22.1%	63729900.0%
7	PRM	Perimeter Solutions	21.1%	102.3%
8	CHRW	C.H. Robinson Worldwide	19.7%	52.6%
9	INSM	Insmed	16.3%	181.3%
10	CAH	Cardinal Health	15.4%	62.8%

1 Day Top Losers

#	Ticker	Company	1D Rtn	YTD Rtn
1	FMC	FMC	-46.5%	-66.6%
2	APLS	Apellis Pharmaceuticals	-31.0%	-35.0%
3	THRY	Thryv	-30.2%	-44.8%
4	SFM	Sprouts Farmers Market	-26.1%	-39.2%
5	IART	Integra Lifesciences	-23.5%	-47.9%
6	ITRI	Itron	-21.1%	0.4%
7	WOLF	Wolfspeed	-18.2%
8	CMG	Chipotle Mexican Grill	-18.2%	-46.1%
9	CI	Cigna	-17.4%	-9.2%
10	EME	EMCOR	-16.6%	43.0%

1 Week Top Gainers

#	Ticker	Company	1W Rtn	YTD Rtn
1	INBX	Inhibrx Biosciences	176.8%	409.8%
2	PUMP	ProPetro	71.2%	16.2%
3	RNA	Avidity Biosciences	43.5%	139.6%
4	DYN	Dyne Therapeutics	42.8%	-0.0%
5	GCI	Gannett	39.3%	3.8%
6	FORM	FormFactor	38.3%	34.7%
7	MBX	MBX Biosciences	35.1%	18.2%
8	BBNX	Beta Bionics	33.8%
9	GH	Guardant Health	33.3%	202.5%
10	LUMN	Lumen Technologies	32.7%	94.7%

1 Week Top Losers

#	Ticker	Company	1W Rtn	YTD Rtn
1	PMI	Picard Medical	-75.2%	5106.3%
2	LRN	Stride	-56.1%	-35.8%
3	NTLA	Intellia Therapeutics	-52.6%	5.2%
4	FMC	FMC	-48.7%	-66.6%
5	FI	Fiserv	-47.4%	-68.3%
6	VRNS	Varonis Systems	-43.8%	-21.2%
7	THRY	Thryv	-33.4%	-44.8%
8	NFE	New Fortress Energy	-30.5%	-91.9%
9	AKBA	Akebia Therapeutics	-29.5%	10.5%
10	UAMY	United States Antimony	-28.9%	371.2%

Peer Comparisons for Cantor Equity Partners I

Financials

	CEPO	BCAR	AEXA	BACC	BRR	CCCX	Median
Name	Cantor E.	D Boral .	American.	Blue Acq.	Columbus.	Churchil.
Mkt Price	10.50	10.05	11.48	10.06	10.21	17.86	10.36
Mkt Cap	0.3	-	-	-	-	-	0.3
Rev LTM	0	-	-	-	-	0	0
Op Inc LTM	-0	-	-	-	-	-0	-0
FCF LTM	-0	-	-	-	-	-1	-0
FCF 3Y Avg	-	-	-	-	-	-	-
CFO LTM	-0	-	-	-	-	-1	-0
CFO 3Y Avg	-	-	-	-	-	-	-

Growth & Margins

	CEPO	BCAR	AEXA	BACC	BRR	CCCX	Median
Name	Cantor E.	D Boral .	American.	Blue Acq.	Columbus.	Churchil.
Rev Chg LTM	-	-	-	-	-	-	-
Rev Chg 3Y Avg	-	-	-	-	-	-	-
Rev Chg Q	-	-	-	-	-	-	-
QoQ Delta Rev Chg LTM	-	-	-	-	-	-	-
Op Mgn LTM	-	-	-	-	-	-	-
Op Mgn 3Y Avg	-	-	-	-	-	-	-
QoQ Delta Op Mgn LTM	-	-	-	-	-	-	-
CFO/Rev LTM	-	-	-	-	-	-	-
CFO/Rev 3Y Avg	-	-	-	-	-	-	-
FCF/Rev LTM	-	-	-	-	-	-	-
FCF/Rev 3Y Avg	-	-	-	-	-	-	-

Valuation

	CEPO	BCAR	AEXA	BACC	BRR	CCCX	Median
Name	Cantor E.	D Boral .	American.	Blue Acq.	Columbus.	Churchil.
Mkt Cap	0.3	-	-	-	-	-	0.3
P/S	-	-	-	-	-	-	-
P/EBIT	-656.2	-	-	-	-	-	-656.2
P/E	92.1	-	-	-	-	-	92.1
P/CFO	-3,278.8	-	-	-	-	-	-3,278.8
Total Yield	1.1%	-	-	-	-	-	1.1%
Dividend Yield	0.0%	-	-	-	-	-	0.0%
FCF Yield 3Y Avg	-	-	-	-	-	-	-
D/E	0.0	-	-	-	-	-	0.0
Net D/E	0.0	-	-	-	-	-	0.0

Returns

	CEPO	BCAR	AEXA	BACC	BRR	CCCX	Median
Name	Cantor E.	D Boral .	American.	Blue Acq.	Columbus.	Churchil.
1M Rtn	0.4%	1.2%	5.0%	0.6%	0.9%	38.9%	1.0%
3M Rtn	-4.1%	-	-	-	-1.6%	76.0%	-1.6%
6M Rtn	-12.0%	-	-	-	-	-	-12.0%
12M Rtn	656,150.0%	-	-	-	-	-	656,150.0%
3Y Rtn	656,150.0%	-	-	-	-	-	656,150.0%
1M Excs Rtn	-1.4%	-0.4%	3.5%	-1.1%	-0.8%	36.9%	-0.6%
3M Excs Rtn	-13.0%	-	-	-	-10.2%	66.8%	-10.2%
6M Excs Rtn	-33.7%	-	-	-	-	-	-33.7%
12M Excs Rtn	656,132.8%	-	-	-	-	-	656,132.8%
3Y Excs Rtn	656,073.2%	-	-	-	-	-	656,073.2%

Financials

Annual
Quarterly

$ Mil \| FY: 12/31	LTM	2024	2023	2022
Period End	6/30/2025	12/31/2024	12/31/2023	12/31/2022
Filing Date	8/14/2025	3/28/2025	1/7/2025	11/1/2024
Key Financials
Total Revenue	0	0	0	0
Net Income	3	-0	-0	-0
EPS	0.12	-0.00	-0.00	-0.00
Growth Rates
Total Revenue Growth	-	-	-	-
Net Income Growth	6316.3%	-2330.9%	44.8%	-
Margins
Net Income Margin	-	-	-	-
Cash & Debt
Total Cash	0	�	�	�
Total Debt	0	0	0	0
Net Debt / (Cash)	0	�	�	�
Cash Flows
Net Cash from Operations	-0	-0	0	0
Free Cash from Operations	-0	-0	0	0
Returns to Shareholders
Dividends	0	-0	-0	-0
Share Repurchases	-0	-0	-0	-0

$ Mil \| FY: 12/31	2025Q2	2025Q1	2024Q4	2024Q3	2024Q2	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1
Period End	6/30/2025	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023
Filing Date	8/14/2025	5/15/2025	3/28/2025	1/7/2025	9/6/2024	7/1/2024	1/7/2025	11/1/2024	9/6/2024	7/1/2024
Key Financials Quarterly
Total Revenue	0	0	0	0	0	0	0	0	0	0
Net Income	2	1	-0	-0	-0	0	-0	0	0	0
EPS	0.08	0.04	-0.00	-0.00	-0.00	0.00	-0.00	0.00	0.00	0.00
Key Financials TTM
Total Revenue TTM	0	0	0	0	0	0	0	-	-	-
Net Income TTM	3	1	-0	-0	-0	-0	-0	-	-	-
Growth Rates Quarterly
Total Revenue Growth	-	-	-	-	-	-	-	-	-	-
Net Income Growth	4615.6%	-	-679.4%	-	-	-	-	-	-	-
Margins Quarterly
Net Income Margin	-	-	-	-	-	-	-	-	-	-
Cash & Debt
Total Cash	0	0	-	-	-	-	-	-	-	-
Total Debt	0	0	0	0	0	0	0	0	0	0
Net Debt / (Cash)	0	-0	-	-	-	-	-	-	-	-
Cash Flows Quarterly
FCF from Operations	-0	0	-0	-0	0	0	0	0	0	0
Cash Flows TTM
FCF from Operations TTM	-0	-0	-0	-0	0	0	0	-	-	-
Returns to Shareholders Quarterly
Dividends	0	0	0	0	0	0	0	0	0	0
Share Repurchases	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0
Return on Invested Capital (ROIC) Quarterly
ROIC	-0.3%	-0.4%	-68.0%	-51.3%	-692.8%	0.0%	-55.6%	-	-	-
Return on Invested Capital (ROIC) TTM
ROIC TTM	-0.2%	-0.1%	-53.0%	-55.5%	-187.1%	-13.9%	-13.9%	-	-	-

Price Behavior

Price Behavior

Market Price	$10.50
Market Cap ($ Bil)	0.3
First Trading Date	01/03/2007
Distance from 52W High	-31.1%
	50 Days	200 Days
DMA Price	$10.28	$10.28
DMA Trend	indeterminate	down
Distance from DMA	2.2%	2.2%
	3M	1YR
Volatility	12.9%	39.0%
Downside Capture	58.31	15.84
Upside Capture	17.49	18.15
Correlation (SPY)	27.6%	-6.1%

CEPO Betas & Captures as of 9/30/2025

	1M	2M	3M	6M	1Y	3Y
Beta	-0.10	0.64	-0.20	0.09	-2013.15	-941.59
Up Beta	-0.82	1.30	-0.09	0.15	0.13	0.07
Down Beta	0.46	0.16	-2.55	-0.14	-2232.86	-1518.60
Up Capture	-3%	21%	-2%	18%	9%	1%
Bmk +ve Days	13	23	35	74	144	420
Stock +ve Days	10	17	25	57	81	81
Down Capture	-7%	97%	122%	31%	-1000806%	-629174%
Bmk -ve Days	8	19	29	52	107	330
Stock -ve Days	9	22	34	58	74	74

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively

Short Interest

Short Interest: As Of Date	10152025
Short Interest: Shares Quantity	22,964
Short Interest: % Change Since 9302025	-1.8%
Average Daily Volume	270,563
Days-to-Cover Short Interest	1
Basic Shares Quantity	25,500,000
Short % of Basic Shares	0.1%

Returns Analyses

	Title
0	How Low Can Cantor Equity Partners I Stock Really Go?

SEC Filings

Expand for More

Report Date	Filing Date	Filing
6302025	8142025	10-Q 6/30/2025
3312025	5152025	10-Q 3/31/2025
12312024	3282025	10-K 12/31/2024
6302024	9062024	DRS/A 6/30/2024
3312024	7012024	DRS 3/31/2024
12312023	1072025	424B4 12/31/2023
12312022	11012024	S-1 12/31/2022

Insider Activity

Expand for More

	Owner	Title	Filing Date	Action	Price	Shares	Transacted Value	Value of Held Shares	Form
0	Cantor EP Holdings I, LLC		1102025	Buy	10.00	500,000	5,000,000	5,000,000	Form

Industry Resources

Financials Resources

Federal Reserve Economic Data

External Quote Links

0	Y Finance	Barrons
1	TradingView	Morningstar
2	SeekingAlpha	ValueLine
3	Motley Fool	Robinhood
4	CNBC	Etrade
5	MarketWatch	Unusual Whales
6	YCharts	Perplexity Finance
7	FinViz

Prefer one of these to Trefis? Tell us why.

Cantor Equity Partners I (CEPO)

Market Price (10/31/2025): $10.51 | Market Cap: $268.0 MilSector: Financials | Industry: Multi-Sector Holdings

Cantor Equity Partners I (CEPO)

Market Price (10/31/2025): $10.51Market Cap: $268.0 MilSector: FinancialsIndustry: Multi-Sector Holdings

Market Valuation & Key Metrics

CEPO Stock

Return vs. Risk

Price Returns Compared

How Low Can It Go

In The Past

Preserve Wealth

Asset Allocation

About Cantor Equity Partners I (CEPO)

Interactive Breakdown

Better Bets than Cantor Equity Partners I (CEPO)

Latest Trefis Analyses

Trade Ideas

Recent Active Movers

1 Day Top Gainers

1 Day Top Losers

1 Week Top Gainers

1 Week Top Losers

1 Month Top Gainers

1 Month Top Losers

Recent Active Movers

1 Day Top Gainers

1 Day Top Losers

1 Week Top Gainers

1 Week Top Losers

More From Trefis

Research & Analysis

Invest in Strategies

Wealth Management

Peer Comparisons for Cantor Equity Partners I

Financials

Growth & Margins

Valuation

Returns

Comparison Analyses

FDIC Bank Data

Bank Capital

Bank Deposits

Bank Assets

Bank Loans

Financials

Segment Financials

Price Behavior

Short Interest

Returns Analyses

Earnings Returns History

SEC Filings

Insider Activity

Industry Resources

External Quote Links

Market Price (10/31/2025): $10.51 | Market Cap: $268.0 Mil
Sector: Financials | Industry: Multi-Sector Holdings

Market Price (10/31/2025): $10.51
Market Cap: $268.0 Mil
Sector: Financials
Industry: Multi-Sector Holdings